Corneal Descemetocele Management with Multi-Layer Amniotic Membrane Transplantation in an Ocular Graft-versus-Host Disease Case
- PMID: 37893451
- PMCID: PMC10607979
- DOI: 10.3390/medicina59101733
Corneal Descemetocele Management with Multi-Layer Amniotic Membrane Transplantation in an Ocular Graft-versus-Host Disease Case
Abstract
Background: Chronic ocular graft-versus-host disease (oGVHD) is a common ocular complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT), characterized by progressive inflammation of the ocular surface and refractory dry eye. In severe cases, sterile corneal perforation can occur, which poses a significant challenge, due to the low survival rate of grafts after corneal transplantation. Case Presentation: A 47-year-old female presented to our hospital with persistent dryness, foreign body sensation, and blurred vision in her left eye. Diagnosis of graft-versus-host disease with corneal descemetocele in the left eye was made after detailed history review and thorough examination. Multi-layer amniotic membrane transplantation was performed in the affected eye, resulting in amelioration of the patient's symptoms. This amelioration of symptoms provided the patient with a level of comfort that permitted additional time while awaiting corneal transplantation. Conclusions: We report a successful case of multi-layer amniotic membrane transplantation for the management of corneal descemetocele following allo-HSCT.
Keywords: amniotic membrane transplantation; case report; corneal descemetocele; ocular graft-versus-host disease (oGVHD); sterile corneal melting.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
[Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases].J Fr Ophtalmol. 2001 Oct;24(8):798-812. J Fr Ophtalmol. 2001. PMID: 11894530 French.
-
Two case reports of continued progression of chronic ocular graft-versus-host disease without concurrent systemic comorbidities treated by amniotic membrane transplantation.BMC Ophthalmol. 2021 Apr 7;21(1):164. doi: 10.1186/s12886-021-01925-3. BMC Ophthalmol. 2021. PMID: 33827493 Free PMC article.
-
Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.Eur J Ophthalmol. 2014 Sep-Oct;24(5):655-66. doi: 10.5301/ejo.5000451. Epub 2014 Mar 7. Eur J Ophthalmol. 2014. PMID: 24604604
-
Immunopathological mechanisms and clinical manifestations of ocular graft-versus-host disease following hematopoietic stem cell transplantation.Bone Marrow Transplant. 2024 Aug;59(8):1049-1056. doi: 10.1038/s41409-024-02321-3. Epub 2024 May 31. Bone Marrow Transplant. 2024. PMID: 38822141 Review.
-
Long-Term Descemetocele Management With Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Treatment.Eye Contact Lens. 2020 Mar;46(2):e7-e10. doi: 10.1097/ICL.0000000000000602. Eye Contact Lens. 2020. PMID: 30985491 Review.
Cited by
-
The Necroptosis Pathway Is Upregulated in the Cornea in Mice With Ocular Graft-Versus-Host Disease.Invest Ophthalmol Vis Sci. 2024 Aug 1;65(10):38. doi: 10.1167/iovs.65.10.38. Invest Ophthalmol Vis Sci. 2024. PMID: 39189995 Free PMC article.
-
Amniotic Membrane Transplantation for Wound Healing, Tissue Regeneration and Immune Modulation.Stem Cell Rev Rep. 2025 Jun;21(5):1428-1448. doi: 10.1007/s12015-025-10892-x. Epub 2025 May 14. Stem Cell Rev Rep. 2025. PMID: 40366553 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical